Literature DB >> 7923087

Cytogenetic findings in 21 malignant melanomas.

Y Y Ozisik1, A M Meloni, O Altungoz, A Peier, C Karakousis, S P Leong, A A Sandberg.   

Abstract

Cytogenetic analysis was performed on 21 tumor samples of malignant melanoma to identify the presence of consistent chromosome abnormalities. Four cases had a normal karyotype, and 17 were cytogenetically abnormal. Numerical chromosome alterations were observed in 15 tumors: 12 were hyperdiploid and three were hypodiploid. The most frequent losses consisted of chromosomes 5, 9, 17 and Y. The structural abnormalities were usually complex, consisting mainly of nonreciprocal translocations and deletions affecting 1p, 1q, 3p, and 9p. This study adds further data to previously reported melanoma cases, confirming that chromosomes 1, 3, 6, and 9 are nonrandomly affected.

Entities:  

Mesh:

Year:  1994        PMID: 7923087     DOI: 10.1016/0165-4608(94)90152-x

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  4 in total

1.  Chromosome 7 aneusomy. A marker for metastatic melanoma? Expression of the epidermal growth factor receptor gene and chromosome 7 aneusomy in nevi, primary malignant melanomas and metastases.

Authors:  M Udart; J Utikal; G M Krähn; R U Peter
Journal:  Neoplasia       Date:  2001 May-Jun       Impact factor: 5.715

2.  Y chromosome aneuploidy, micronuclei, kinetochores and aging in men.

Authors:  J Nath; J D Tucker; J C Hando
Journal:  Chromosoma       Date:  1995-07       Impact factor: 4.316

3.  Network-guided analysis of genes with altered somatic copy number and gene expression reveals pathways commonly perturbed in metastatic melanoma.

Authors:  Armand Valsesia; Donata Rimoldi; Danielle Martinet; Mark Ibberson; Paola Benaglio; Manfredo Quadroni; Patrice Waridel; Muriel Gaillard; Mireille Pidoux; Blandine Rapin; Carlo Rivolta; Ioannis Xenarios; Andrew J G Simpson; Stylianos E Antonarakis; Jacques S Beckmann; C Victor Jongeneel; Christian Iseli; Brian J Stevenson
Journal:  PLoS One       Date:  2011-04-08       Impact factor: 3.240

4.  Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases.

Authors:  G M Kraehn; J Utikal; M Udart; K M Greulich; G Bezold; P Kaskel; U Leiter; R U Peter
Journal:  Br J Cancer       Date:  2001-01-05       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.